Therapeutic Approach of Cardiovascular Risk Factors in T2DM by Gender
NCT ID: NCT04653805
Last Updated: 2023-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300000 participants
OBSERVATIONAL
2017-01-31
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: The cardiovascular risk factors management in women with T2DM is different than in men with T2DM.
Aims: To assess the therapeutic approach of cardiovascular risk factors and the occurrence of cardiovascular events among women in comparison to men with T2DM.
Methodology: Observational study based on clinical records of primary health care from T2DM patients in Catalonia (2007-2013).
Source: SIDIAP database. Analysis: The two study groups (women and men) will be matched to ensure balance in terms of basal comorbidities and previous cardiovascular disease in order to describe the study group characteristics and to perform a multivariate modeling approach.
Applicability and Relevance: This study is intended to serve to identify the points of improvement of the cardiovascular risk factors therapeutic approach in women.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise and Type 2 Diabetes: Gender and Endothelial Function
NCT01993121
Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes
NCT02542774
Home-based Heat Therapy for Type 2 Diabetes
NCT05269589
Enhancing Support for Women at Risk for Heart Disease
NCT00142701
Women and Risk of Type 2 Diabetes
NCT03870724
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Current clinical practice in primary care of patients with type 2 diabetes mellitus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a diagnosis of type 2 diabetes (codes ICD10: E11, E11.0-E11.9, E14, E14.0-E14.9) on DTALL-30Jun of each year
Exclusion Criteria
31 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Didac Mauricio Puente, MD, PhD
Role: STUDY_DIRECTOR
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Anna Ramirez-Morros, RN
Role: PRINCIPAL_INVESTIGATOR
Institut Català de la Salut
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IDIAP Jordi Gol
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7Z20/036
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.